MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 12-03-2025
HealthEquity Operating Income 2011-2026 | HQY
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income HealthEquity
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118 M | 9.06 M | -24.2 M | 34 M | 77 M | 77.7 M | 54.4 M | 41.2 M | 26.1 M | 16.9 M | 11.5 M | 7.09 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 118 M | -24.2 M | 37.4 M |
Quarterly Operating Income HealthEquity
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.7 M | 89.6 M | 83.1 M | - | 19.6 M | 58.9 M | 41.6 M | - | 30.9 M | 24.7 M | 23.2 M | - | 5.54 M | -2.41 M | -7.29 M | - | -366 K | -875 K | 4.25 M | - | 11.5 M | 9.03 M | 15.1 M | - | 9.92 M | 24.9 M | 27.7 M | - | 19 M | 21.6 M | 20.5 M | - | 13.6 M | 16.5 M | 15.9 M | - | 9.04 M | 12.7 M | 13.2 M | - | 6.3 M | 7.5 M | 7.98 M | - | 4.29 M | 5.07 M | 5.49 M | - | 3.4 M | 3.61 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 89.6 M | -7.29 M | 19.3 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B |  USA |
 |
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | USA |
 |
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | USA |
 |
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M | USA |
 |
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | USA |
 |
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
3.64 M | $ 4.0 | -1.23 % | $ 375 M | USA |
 |
Health Catalyst
HCAT
|
-69.8 M | $ 2.39 | 0.42 % | $ 144 M | USA |
 |
HealthStream
HSTM
|
21.3 M | $ 23.07 | -0.86 % | $ 701 M | USA |
 |
Akerna Corp.
KERN
|
-17.7 M | - | - | $ 161 M | USA |
 |
MTBC
MTBC
|
9.12 M | - | -0.58 % | $ 51.7 M | USA |
 |
American Well Corporation
AMWL
|
-218 M | $ 4.91 | 2.29 % | $ 73.6 M | USA |
 |
Progyny
PGNY
|
15.8 M | $ 25.68 | -0.62 % | $ 2.2 B | USA |
 |
Premier
PINC
|
1.12 M | $ 28.26 | - | $ 2.33 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | USA |
 |
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 12.26 | -1.05 % | $ 210 M | USA |
 |
GoodRx Holdings
GDRX
|
65.8 M | $ 2.71 | 0.74 % | $ 1.05 B | USA |
 |
Omnicell
OMCL
|
337 K | $ 45.3 | -1.35 % | $ 2.09 B | USA |
 |
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | USA |
 |
So-Young International
SY
|
-624 M | $ 2.56 | 1.59 % | $ 203 M |  China |
 |
Phreesia
PHR
|
-136 M | $ 16.92 | -0.65 % | $ 923 M | USA |
 |
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | USA |
 |
10x Genomics
TXG
|
-265 M | $ 16.31 | 0.12 % | $ 1.91 B | USA |
 |
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | USA |
 |
Schrödinger
SDGR
|
-209 M | $ 17.88 | 0.45 % | $ 1.3 B | USA |
 |
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | USA |
 |
Zhongchao
ZCMD
|
-341 K | $ 0.45 | -26.63 % | $ 2.34 M | China |
 |
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-1.02 B | $ 7.0 | - | $ 1.19 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
429 M | $ 223.23 | -0.63 % | $ 35.8 B | USA |
 |
SCWorx Corp.
WORX
|
-1.26 M | $ 0.19 | -5.66 % | $ 277 K | USA |